Dr Thilo Sandner (photo) replaces company founder Dr Stefan Sandner as Diapharm’s principal shareholder.
Company founder Dr Stefan Sandner, who has been at the helm of Diapharm for more than 30 years, is handing over the reins of the company.
Company founder Dr Stefan Sandner, who has been at the helm of Diapharm for more than 30 years, is handing over the reins of the company. He will continue to act as a strategic consultant for Diapharm.
Since Dr Thilo Sandner took over responsibility for the company, he has further developed the strengths that Diapharm has acquired over the last 30 years. Diapharm is currently ramping up its workforce by another 10%. “The challenges can only be mastered with more capacity and expertise; more colleagues have been recruited. The focus of our success is on performance, the advancement of our employees and the development of expertise in the various specialist departments,” Sandner explains. “More than anything, we owe our dynamic growth to the commitment of our employees!”
As an experienced business consultant, Dr Thilo Sandner not only has the operational requirements of day-to-day business in mind, but also the optimisation of structures within the company. “The coming months will be characterised by planning, decision-making and the implementation of structural and sales tasks.”
Around 100 employees at Diapharm provide consulting services to clients from all sectors of the healthcare industry on strategic queries, assuming responsibility for regulatory, medical and scientific tasks and providing support in the area of quality assurance.
Before moving to Diapharm, the new principal shareholder Dr Thilo Sandner worked at the pharmaceutical consulting firm Charles River Associates (formerly Cepton Strategies) in Munich and New York.
(approx. 2,070 characters)